1. Home
  2. AMG vs ABVX Comparison

AMG vs ABVX Comparison

Compare AMG & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Affiliated Managers Group Inc.

AMG

Affiliated Managers Group Inc.

HOLD

Current Price

$329.25

Market Cap

7.6B

Sector

Finance

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$123.58

Market Cap

9.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMG
ABVX
Founded
1993
2013
Country
United States
France
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
9.2B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
AMG
ABVX
Price
$329.25
$123.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$335.20
$130.09
AVG Volume (30 Days)
381.9K
2.0M
Earning Date
02-02-2026
08-11-2025
Dividend Yield
0.01%
N/A
EPS Growth
6.83
N/A
EPS
16.71
N/A
Revenue
$2,042,100,000.00
$6,231,374.00
Revenue This Year
$3.63
$6.80
Revenue Next Year
$13.85
N/A
P/E Ratio
$19.63
N/A
Revenue Growth
1.13
N/A
52 Week Low
$139.22
$4.77
52 Week High
$331.73
$148.83

Technical Indicators

Market Signals
Indicator
AMG
ABVX
Relative Strength Index (RSI) 75.30 50.00
Support Level $317.10 $113.64
Resistance Level $311.51 $122.50
Average True Range (ATR) 7.78 8.60
MACD 1.20 -0.99
Stochastic Oscillator 88.35 43.88

Price Performance

Historical Comparison
AMG
ABVX

About AMG Affiliated Managers Group Inc.

Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of June 2025, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 19% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (24%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (57%)—had $771 billion in managed assets.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: